MoonLake ImmunotherapeuticsMLTXNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
-43.9%/yr
Quarterly compound
Percentile
P65
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 15.45% |
| Q3 2025 | -26.44% |
| Q2 2025 | -38.10% |
| Q1 2025 | 12.50% |
| Q4 2024 | -28.57% |
| Q3 2024 | -43.59% |
| Q2 2024 | -77.27% |
| Q1 2024 | -83.33% |
| Q4 2023 | 33.33% |
| Q3 2023 | 21.74% |
| Q2 2023 | 25.81% |
| Q1 2023 | -522.49% |
| Q4 2022 | 87.55% |
| Q3 2022 | 18.37% |
| Q2 2022 | -13.95% |
| Q1 2022 | -614.29% |
| Q4 2021 | 64.59% |
| Q3 2021 | 80.90% |
| Q2 2021 | -17015.38% |
| Q1 2021 | 10.34% |
| Q4 2020 | 0.00% |